Abstract
Oral squamous cell carcinoma (OSCC) is among the most prevalent cancers worldwide. Despite the advances in disease management, the survival rates have not improved in the last decades, remaining around 50-60% in 5 years. The tools currently available for clinical staging and treatment decision have not been effective in improving these rates. Therefore, it is necessary to identify and val…